Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ernexa Therapeutics (ERNA) Treasury Shares (2016 - 2024)

Historic Treasury Shares for Ernexa Therapeutics (ERNA) over the last 11 years, with Q4 2020 value amounting to $456000.0.

  • Ernexa Therapeutics' Treasury Shares changed 0.0% to $456000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $456000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $456000.0 for FY2020, which is 0.0% changed from last year.
  • As of Q3 2024, Ernexa Therapeutics' Treasury Shares stood at $1000.0, which was down 0.0% from $1000.0 recorded in Q2 2024.
  • In the past 5 years, Ernexa Therapeutics' Treasury Shares ranged from a high of $1.3 million in Q1 2022 and a low of $1000.0 during Q1 2023
  • Moreover, its 4-year median value for Treasury Shares was $4000.0 (2022), whereas its average is $151153.8.
  • The largest annual percentage gain for Ernexa Therapeutics' Treasury Shares in the last 5 years was 0.0% (2016), contrasted with its biggest fall of 0.0% (2016).
  • Ernexa Therapeutics' Treasury Shares (Quarter) stood at $456000.0 in 2016, then changed by 0.0% to $456000.0 in 2017, then changed by 0.0% to $456000.0 in 2018, then changed by 0.0% to $456000.0 in 2019, then changed by 0.0% to $456000.0 in 2020.
  • Its last three reported values are $456000.0 in Q4 2020, $456000.0 for Q3 2020, and $456000.0 during Q1 2020.